Cargando…

Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2

AIMS: Glioblastoma (GBM) is the most common and lethal malignant brain tumor in adults. Glioma stem cells (GSCs) are implicated in this poor prognosis and in radio(chemo‐)resistance. We have previously demonstrated that among potentially highly specific GSC markers oligodendrocyte lineage transcript...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouchart, Christelle, Trépant, Anne‐Laure, Hein, Matthieu, Van Gestel, Dirk, Demetter, Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997071/ https://www.ncbi.nlm.nih.gov/pubmed/31568682 http://dx.doi.org/10.1002/cam4.2592

Ejemplares similares

Profiling Glioblastoma Cases with an Expression of DCX, OLIG2 and NES
por: Odrzywolski, Adrian, et al.
Publicado: (2021)

IGF-IR: a new prognostic biomarker for human glioblastoma
por: Maris, C, et al.
Publicado: (2015)

MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer
por: Li, Wen-Cui, et al.
Publicado: (2019)

OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM)
por: Zhou, Jia, et al.
Publicado: (2023)

Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome
por: Chakrabarti, Lina, et al.
Publicado: (2010)

Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma
por: Tsigelny, Igor F., et al.
Publicado: (2015)

Ultraconserved Elements in the Olig2 Promoter
por: Chen, Christina T. L., et al.
Publicado: (2008)

MiR‐646 suppresses proliferation and metastasis of non‐small cell lung cancer by repressing FGF2 and CCND2
por: Wang, Jing, et al.
Publicado: (2020)

Gene clusters based on OLIG2 and CD276 could distinguish molecular profiling in glioblastoma
por: Fu, Minjie, et al.
Publicado: (2021)

EMBR-02. OLIG2 REPRESENTS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN MYC-AMPLIFIED MEDULLOBLASTOMA RELAPSE AND METASTASIS
por: Xu, Zhenhua, et al.
Publicado: (2021)

Induction of Olig2(+) Precursors by FGF Involves BMP Signalling Blockade at the Smad Level
por: Bilican, Bilada, et al.
Publicado: (2008)

Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice
por: Yang, Tao, et al.
Publicado: (2017)

The current understanding of the immune landscape relative to radiotherapy across tumor types
por: Iliadi, Chrysanthi, et al.
Publicado: (2023)

CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3
por: Turchi, Laurent, et al.
Publicado: (2023)

GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription
por: Zhang, Shanshan, et al.
Publicado: (2019)

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
por: Manderlier, Martin, et al.
Publicado: (2022)

Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind
por: Arsenijevic, Tatjana, et al.
Publicado: (2021)

Identifying an oligodendrocyte enhancer that regulates Olig2 expression
por: Fan, Chuandong, et al.
Publicado: (2022)

Implications of Olig2 silencing in oligodendrocyte precursor cells
por: Fang, Li-Pao, et al.
Publicado: (2023)

CBMS-03 PHOSPHORYLATION STATE OF OLIG2 REGULATES PROLIFERATION OF GLIOMA STEM CELLS
por: Saito, Norihiko, et al.
Publicado: (2019)

Retraction Note: Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice
por: Yang, Tao, et al.
Publicado: (2023)

Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma
por: Behling, Felix, et al.
Publicado: (2020)

GLI3 Is Required for OLIG2+ Progeny Production in Adult Dorsal Neural Stem Cells
por: Embalabala, Rebecca J., et al.
Publicado: (2022)

OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms
por: Otero, José Javier, et al.
Publicado: (2010)

Molecular mechanisms of OLIG2 transcription factor in brain cancer
por: Tsigelny, Igor F., et al.
Publicado: (2016)

A Systematic Enhancer Screen Using Lentivector Transgenesis Identifies Conserved and Non-Conserved Functional Elements at the Olig1 and Olig2 Locus
por: Friedli, Marc, et al.
Publicado: (2010)

EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
por: Krusche, Benjamin, et al.
Publicado: (2016)

Crizotinib targets in glioblastoma stem cells
por: Junca, Audelaure, et al.
Publicado: (2017)

Impact of the Olig Family on Neurodevelopmental Disorders
por: Szu, Jenny, et al.
Publicado: (2021)

New Olig1 null mice confirm a non-essential role for Olig1 in oligodendrocyte development
por: Paes de Faria, Joana, et al.
Publicado: (2014)

Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients
por: Kefayat, Amirhosein, et al.
Publicado: (2021)

Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids
por: Pinto, Giulia, et al.
Publicado: (2021)

MicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3
por: MO, XIAOMEI, et al.
Publicado: (2016)

CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling
por: Zhang, Wen-Yuan, et al.
Publicado: (2019)

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
por: Bouchart, Christelle, et al.
Publicado: (2020)

Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Li, Fazhan, et al.
Publicado: (2021)

LAST, a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote CCND1 mRNA stability in human cells
por: Cao, Limian, et al.
Publicado: (2017)

OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas
por: Kaleta, Magdalena, et al.
Publicado: (2019)

Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor–induced astrocyte differentiation
por: Setoguchi, Takao, et al.
Publicado: (2004)

Olig2-expressing Mesenchymal Stem Cells Enhance Functional Recovery after Contusive Spinal Cord Injury
por: Park, Hwan-Woo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1v66aeeg73obgvi4c41b0ccafr